Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Novartis announces Russian regulatory approval for Gilenya®, a once-daily oral multiple sclerosis therapy and first in a new class
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
Effect of vitamin D on MS activity by disease-modifying therapy class.
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
Autoimmune sleep disorders.
Reassessing the risk of natalizumab-associated PML.
8th Annual Symposium on Glial-Neuronal Interactions
Genzyme’s once-daily, oral AUBAGIO® (teriflunomide) approved in Argentina for the treatment of relapsing multiple sclerosis
Clarity Extension Study
Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis.
BRIEF: Teva files for Copaxone-Laquinimod patent
Movement and structure of mitochondria in oligodendrocytes and their myelin sheaths.
Moving Targets for Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
Development of Guillain-Barré syndrome in a patient with multiple sclerosis during treatment with glatiramer acetate.
Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors - Implications for dose-sparing combination therapies.
FOCIS: Advanced Course in Basic & Clinical Immunology
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?
Women's Issues in Multiple Sclerosis.
Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Neurovascular and Immuno-Imaging Symposium
CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis.

Pages